Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker

Alexander P. Sung, Jennifer J-J Tang, Michael J. Guglielmo, Julie Smith-Gagen, Lucinda Bateman, Doug D. Redelman, Dorothy Hudig
doi: https://doi.org/10.1101/2019.12.20.19015438

Article Information

doi 
https://doi.org/10.1101/2019.12.20.19015438
History 
  • December 27, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Alexander P. Sung1,
  2. Jennifer J-J Tang1,
  3. Michael J. Guglielmo1,
  4. Julie Smith-Gagen2,
  5. Lucinda Bateman3,
  6. Doug D. Redelman† and
  7. Dorothy Hudig1,*
  1. 1University of Nevada, Reno School of Medicine, Reno, NV
  2. 2University of Nevada, Reno Health Sciences
  3. 3Bateman Horne Center, Salt Lake City, UT
  4. †Deceased, University of Nevada, Reno School of Medicine, Reno, NV
  1. ↵*Corresponding author:
    Dorothy Hudig, Ph.D., Telephone (775) 784-4430, FAX (775) 327-2332, Email dhudig{at}unr.edu
Back to top
Posted December 27, 2019.
Download PDF

Supplementary Material

Data/Code
Email
Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker
Alexander P. Sung, Jennifer J-J Tang, Michael J. Guglielmo, Julie Smith-Gagen, Lucinda Bateman, Doug D. Redelman, Dorothy Hudig
medRxiv 2019.12.20.19015438; doi: https://doi.org/10.1101/2019.12.20.19015438
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area